Protein kinase Cδ stimulates proteasome-dependent degradation of C/EBPα during apoptosis induction of leukemic cells

PLoS ONE

Volumn 4, Issue 8, 2009, Pages

  Zhao, Meng ^a   Duan, Xu Fang ^a   Zhao, Xu Yun ^a   Zhang, Bo ^a   Lu, Ying ^a   Liu, Wei ^a   Cheng, Jin Ke ^a   Chen, Guo Qiang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; CYCLOHEXIMIDE; ETOPOSIDE; LUCIFERASE; NSC 606985; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN KINASE C DELTA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; CASPASE 3; MESSENGER RNA; PRIMER DNA;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; INHIBITION KINETICS; LEUKEMIA; LEUKEMIA CELL LINE; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION TERMINATION; UBIQUITINATION; DOWN REGULATION; DRUG EFFECT; ENZYMOLOGY; GENETIC TRANSCRIPTION; GENETICS; HYDROLYSIS; METABOLISM; PATHOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

METAZOA;

APOPTOSIS; BASE SEQUENCE; BLOTTING, WESTERN; CASPASE 3; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL LINE, TUMOR; DNA PRIMERS; DOWN-REGULATION; ETOPOSIDE; GENE SILENCING; HUMANS; HYDROLYSIS; LEUKEMIA; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN KINASE C-DELTA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC; UBIQUITINATION;

EID: 68449094954     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006552     Document Type: Article

References (61)

1. Droin N, Cathelin S, Jacquel A, Guery L,Garrido C, et al. (2008) A role for caspases in the differentiation of erythroid cells and macrophages. Biochimie 90: 416-422.
2. Lu QL, Abel P, Foster CS, Lalani EN (1996) bcl-2: role in epithelial differentiation and oncogenesis. Hum Pathol 27: 102-110.
3. Zhang DE, Zhang P, Wang ND, Hetherington CJ, Darlington GJ, et al. (1997) Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. Proc Natl Acad Sci U S A 94: 569-574.
4. Radomska HS, Huettner CS, Zhang P, Cheng T, Scadden DT, et al. (1998) CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol Cell Biol 18: 4301-4314.
5. Schuster MB, Porse BT (2006) C/EBPalpha: a tumour suppressor in multiple tissues? Biochim Biophys Acta 1766: 88-103.
6. Nerlov C (2004) C/EBPalpha mutations in acute myeloid leukaemias. Nat Rev Cancer 4: 394-400.
7. Pabst T, Mueller BU, Harakawa N, Schoch C, Haferlach T, et al. (2001) AML1-ETO downregulates the granulocytic differentiation factor C/ EBPalpha in t(8;21) myeloid leukemia. Nat Med 7: 444-451.
8. Westendorf JJ, Yamamoto CM, Lenny N, Downing JR, Selsted ME, et al. (1998) The t(8;21) fusion product, AML-1-ETO, associates with C/ EBP-alpha, inhibits C/EBP-alpha-dependent transcription, and blocks granulocytic differentiation. Mol Cell Biol 18: 322-333.
9. Emoto Y, Kisaki H, Manome Y, Kharbanda S, Kufe D (1996) Activation of protein kinase Cdelta in human myeloid leukemia cells treated with 1-beta-D-arabinofuranosylcytosine. Blood 87: 1990-1996.
10. Perrotti D, Cesi V, Trotta R, Guerzoni C, Santilli G, et al. (2002) BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2. Nat Genet 30: 48-58.
11. Paz-Priel I, Cai DH, Wang D, Kowalski J, Blackford A, et al. (2005) CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50. Mol Cancer Res 3: 585-596.
12. Rapisarda A, Uranchimeg B, Scudiero DA, Selby M, Sausville EA, et al. (2002) Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway. Cancer Res 62: 4316-4324.
13. Liu W, Zhu YS, Guo M, Yu Y, Chen GQ (2007) Therapeutic efficacy of NSC606985, a novel camptothecin analog, in a mouse model of acute promyelocytic leukemia. Leuk Res 31: 1565-1574.
14. Song MG, Gao SM, Du KM, Xu M, Yu Y, et al. (2005) Nanomolar concentration of NSC606985, a camptothecin analog, induces leukemic-cell apoptosis through protein kinase Cdelta-dependent mechanisms. Blood 105: 3714-3721.
15. Porter AG, Janicke RU (1999) Emerging roles of caspase-3 in apoptosis. Cell Death Differ 6: 99-104.
16. Ramji DP, Foka P (2002) CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 365: 561-575.
17. Brodie C, Blumberg PM (2003) Regulation of cell apoptosis by protein kinase c delta. Apoptosis 8: 19-27.
18. Basu A (2003) Involvement of protein kinase C-delta in DNA damage-induced apoptosis. J Cell Mol Med 7: 341-350.
19. Emoto Y, Manome Y, Meinhardt G, Kisaki H, Kharbanda S, et al. (1995) Proteolytic activation of protein kinase C delta by an ICE-like protease in apoptotic cells. Embo J 14: 6148-6156.
20. Reyland ME, Anderson SM, Matassa AA, Barzen KA, Quissell DO (1999) Protein kinase C delta is essential for etoposide-induced apoptosis in salivary gland acinar cells. J Biol Chem 274: 19115-19123.
21. Yu Y, Wang LS, Shen SM, Xia L, Zhang L, et al. (2007) Subcellular proteome analysis of camptothecin analogue NSC606985-treated acute myeloid leukemic cells. J Proteome Res 6: 3808-3818.
22. Sitailo LA, Tibudan SS, Denning MF (2006) The protein kinase C delta catalytic fragment targets Mcl-1 for degradation to trigger apoptosis. J Biol Chem 281: 29703-29710.
23. Soltoff SP (2007) Rottlerin: an inappropriate and ineffective inhibitor of PKCdelta. Trends Pharmacol Sci 28: 453-458.
24. Leitges M, Elis W, Gimborn K, Huber M (2001) Rottlerin-independent attenuation of pervanadate-induced tyrosine phosphorylation events by protein kinase C-delta in hemopoietic cells. Lab Invest 81: 1087-1095.
25. Page K, Li J, Zhou L, Iasvovskaia S, Corbit KC, et al. (2003) Regulation of airway epithelial cell NF-kappa B-dependent gene expression by protein kinase C delta. J Immunol 170: 5681-5689.
26. Matassa AA, Carpenter L, Biden TJ, Humphries MJ, Reyland ME (2001) PKCdelta is required for mitochondrial-dependent apoptosis in salivary epithelial cells. J Biol Chem 276: 29719-29728.
27. Boer J, Bonten-Surtel J, Grosveld G (1998) Overexpression of the nucleoporin CAN/NUP214 induces growth arrest, nucleocytoplasmic transport defects, and apoptosis. Mol Cell Biol 18: 1236-1247.
28. Fischer U, Janicke RU, Schulze-Osthoff K (2003) Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ 10: 76-100.
29. Wang L, Zhao WL, Yan JS, Liu P, Sun HP, et al. (2007) Eriocalyxin B induces apoptosis of t(8;21) leukemia cells through NF-kappaB and MAPK signaling pathways and triggers degradation of AML1-ETO oncoprotein in a caspase-3-dependent manner. Cell Death Differ 14: 306-317.
30. Lu Y, Peng ZG, Yuan TT, Yin QQ, Xia L, et al. (2008) Multi-sites cleavage of leukemogenic AML1-ETO fusion protein by caspase-3 and its contribution to increased apoptotic sensitivity. Leukemia 22: 378-386.
31. Shim M, Smart RC (2003) Lithium stabilizes the CCAAT/enhancer-binding protein alpha (C/EBPalpha) through a glycogen synthase kinase 3 (GSK3)-independent pathway involving direct inhibition of proteasomal activity. J Biol Chem 278: 19674-19681.
32. Meng L, Mohan R, Kwok BH, Elofsson M, Sin N, et al. (1999) Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. Proc Natl Acad Sci U S A 96: 10403-10408.
33. Adams J, Palombella VJ, Sausville EA, Johnson J, Destree A, et al. (1999) Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res 59: 2615-2622.
34. Lin KI, Baraban JM, Ratan RR (1998) Inhibition versus induction of apoptosis by proteasome inhibitors depends on concentration. Cell Death Differ 5: 577-583.
35. Voorhees PM, Dees EC, O'Neil B, Orlowski RZ (2003) The proteasome as a target for cancer therapy. Clin Cancer Res 9: 6316-6325.
36. Yoon K, Smart RC (2004) C/EBPalpha is a DNA damage-inducible p53-regulated mediator of the G1 checkpoint in keratinocytes. Mol Cell Biol 24: 10650-10660.
37. Ghayur T, Hugunin M, Talanian RV, Ratnofsky S, Quinlan C, et al. (1996) Proteolytic activation of protein kinase C delta by an ICE/CED 3-like protease induces characteristics of apoptosis. J Exp Med 184: 2399-2404.
38. Basu A, Akkaraju GR (1999) Regulation of caspase activation and cis-diamminedichloroplatinum(II)-induced cell death by protein kinase C. Biochemistry 38: 4245-4251.
39. Zheng Y, Wang LS, Xia L, Han YH, Liao SH, et al. (2009) NDRG1 is down-regulated in the early apoptotic event induced by camptothecin analogs: the potential role in proteolytic activation of PKC delta and apoptosis. Proteomics 9: 2064-2075.
40. Basu A, Woolard MD, Johnson CL (2001) Involvement of protein kinase C-delta in DNA damage-induced apoptosis. Cell Death Differ 8: 899-908.
41. Yoshida K (2007) PKCdelta signaling: mechanisms of DNA damage response and apoptosis. Cell Signal 19: 892-901.
42. Cross T, Griffiths G, Deacon E, Sallis R, Gough M, et al. (2000) PKC-delta is an apoptotic lamin kinase. Oncogene 19: 2331-2337.
43. Leverrier S, Vallentin A, Joubert D (2002) Positive feedback of protein kinase C proteolytic activation during apoptosis. Biochem J 368: 905-913.
44. Bharti A, Kraeft SK, Gounder M, Pandey P, Jin S, et al. (1998) Inactivation of DNA-dependent protein kinase by protein kinase Cdelta: implications for apoptosis. Mol Cell Biol 18: 6719-6728.
45. Ren J, Datta R, Shioya H, Li Y, Oki E, et al. (2002) p73beta is regulated by protein kinase Cdelta catalytic fragment generated in the apoptotic response to DNA damage. J Biol Chem 277: 33758-33765.
46. Liu J, Chen J, Dai Q, Lee RM(2003) Phospholipid scramblase 3 is themitochondrial target of protein kinase C delta-induced apoptosis. Cancer Res 63: 1153-1156.
47. Park R, Baines JD (2006) Herpes simplex virus type 1 infection induces activation and recruitment of protein kinase C to the nuclear membrane and increased phosphorylation of lamin B. J Virol 80: 494-504.
48. Iturrioz X, Durgan J, Calleja V, Larijani B, Okuda H, et al. (2006) The von Hippel-Lindau tumour-suppressor protein interaction with protein kinase Cdelta. Biochem J 397: 109-120.
49. Walker JL, Castagnino P, Chung BM, Kazanietz MG, Assoian RK (2006) Post-transcriptional destabilization of p21cip1 by protein kinase C in fibroblasts. J Biol Chem 281: 38127-38132.
50. Choi BH, Hur EM, Lee JH, Jun DJ, Kim KT (2006) Protein kinase Cdelta-mediated proteasomal degradation of MAP kinase phosphatase-1 contributes to glutamate-induced neuronal cell death. J Cell Sci 119: 1329-1340.
51. Tang QQ, Jiang MS, Lane MD (1999) Repressive effect of Sp1 on the C/ EBPalpha gene promoter: role in adipocyte differentiation. Mol Cell Biol 19: 4855-4865.
52. Jiang MS, Tang QQ, McLenithan J, Geiman D, Shillinglaw W, et al. (1998) Derepression of the C/EBPalpha gene during adipogenesis: identification of AP-2alpha as a repressor. Proc Natl Acad Sci U S A 95: 3467-3471.
53. Legraverend C, Antonson P, Flodby P, Xanthopoulos KG (1993) High level activity of the mouse CCAAT/enhancer binding protein (C/EBP alpha) gene promoter involves autoregulation and several ubiquitous transcription factors. Nucleic Acids Res 21: 1735-1742.
54. Kockar FT, Foka P, Hughes TR, Kousteni S, Ramji DP (2001) Analysis of the Xenopus laevis CCAAT-enhancer binding protein alpha gene promoter demonstrates species-specific differences in the mechanisms for both auto-activation and regulation by Sp1. Nucleic Acids Res 29: 362-372.
55. Hamada M, Sumi T, Iwai S, Nakazawa M, Yura Y (2006) Induction of endonuclease G-mediated apopotosis in human oral squamous cell carcinoma cells by protein kinase C inhibitor safingol. Apoptosis 11: 47-56.
56. Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F, et al. (1991) NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 77: 1080-1086.
57. Lu Y, Xu YB, Yuan TT, Song MG, Lubbert M, et al. (2006) Inducible expression of AML1-ETO fusion protein endows leukemic cells with susceptibility to extrinsic and intrinsic apoptosis. Leukemia 20: 987-993.
58. Lee KK, Ohyama T, Yajima N, Tsubuki S, Yonehara S (2001) MST, a physiological caspase substrate, highly sensitizes apoptosis both upstream and downstream of caspase activation. J Biol Chem 276: 19276-19285.
59. Xu HM, Liao B, Zhang QJ, Wang BB, Li H, et al. (2004) Wwp2, an E3 ubiquitin ligase that targets transcription factor Oct-4 for ubiquitination. J Biol Chem 279: 23495-23503.
60. Soh JW, Weinstein IB (2003) Roles of specific isoforms of protein kinase C in the transcriptional control of cyclin D1 and related genes. J Biol Chem 278: 34709-34716.
61. Zhao KW, Li X, Zhao Q, Huang Y, Li D, et al. (2004) Protein kinase Cdelta mediates retinoic acid and phorbol myristate acetate-induced phospholipid scramblase 1 gene expression: its role in leukemic cell differentiation. Blood 104: 3731-3738.